Aster Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Aster Capital Management's AXSM Position: Q3 2026 in Review
Aster Capital Management reduced its Axsome Therapeutics (AXSM) stake by 99% in Q3 2026, selling an estimated $527K and leaving 34 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #819.
Aster Capital Management first reported a position in AXSM in Q4 2024 and has held it in 5 quarters since. The position peaked at $601K in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Aster Capital Management held 34 shares of Axsome Therapeutics worth $6.27K as of Q3 2026.
- Aster Capital Management sold 2,423 Axsome Therapeutics shares in Q3 2026, an estimated $527K.
- Axsome Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #819 holding.
- Aster Capital Management first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 5 quarters since.
- Aster Capital Management's Axsome Therapeutics position peaked at $601K in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.